| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
HCWB sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 125.8K | $325.3K | - | |
| CFO | 57.2K | $80.4K | - | |
| Dir | 41.6K | $107.6K | - | |
| VP | 8.7K | $22.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Wong Hing C | Chief Executive Officer | Buy | 23,210 | $2.59 | $59,997.85 | +22.6% | -54.7% | - | |
| Jul 29, 2026 | Garrett Scott T | Director | Buy | 7,736 | $2.59 | $19,997.56 | +22.8% | -54.7% | - | |
| Jul 29, 2026 | Flowers Lee | SVP of Business Development | Buy | 7,736 | $2.59 | $19,997.56 | +810.1% | -54.7% | - | |
| May 22, 2026 | Wong Hing C | Chief Executive Officer | Buy | 113,879 | $1.41 | $160,000.00 | +22.7% | -87.8% | - | |
| May 22, 2026 | Garrett Scott T | Director | Buy | 177,936 | $1.41 | $250,000.08 | +697.7% | -87.8% | - | |
| May 22, 2026 | Byam Rebecca | Chief Financial Officer | Buy | 14,235 | $1.41 | $20,000.18 | +33.1% | -87.8% | - | |
| May 16, 2025 | Wong Hing C | Chief Executive Officer | Buy | 8,054 | $7.45 | $60,002.30 | +1.6% | -51.5% | -86.4% | |
| May 16, 2025 | Winer Gary M53 | Director | Buy | 1,342 | $7.45 | $9,997.90 | +49.1% | -51.5% | -86.4% | |
| May 16, 2025 | Garrett Scott T | Director | Buy | 13,423 | $7.45 | $100,001.35 | +111.1% | -51.5% | -86.4% | |
| May 8, 2025 | Flowers Lee | SVP of Business Development | Buy | 962 | $26.00 | $25,012.00 | +20.2% | -36.8% | -95.4% |